Camlin Fine Sciences quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	520	424	+22.7%
EBITDA	9.3	19.0	−51.3%
EBITDA margin	1.8%	4.5%	−2.7 pts
Profit before tax	−33.7	−5.2	—
Net profit	−33.6	−10.7	—
EPS	−₹1.65	−₹0.53	—

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	520	425	457	460	424	437	433	423	396	402	386	406	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	1.3	23.9	2.9	4.6	8.6	9.6	1.3	12.1	1.9	5.8	1.7	1.8
	521	449	460	464	432	447	435	435	398	407	388	408
	312	121	268	209	226	195	173	223	215	137	156	206
	5.8	18.2	13.7	31.9	17.4	2.4	45.4	53.9	15.8	43.3	39.0	12.3
	−12.5	79.9	−33.4	5.8	−6.4	18.1	−2.3	−57.9	−12.4	81.6	17.4	5.2
	73.4	65.9	63.8	60.3	59.6	50.1	52.0	52.3	51.2	46.2	45.5	43.2
	14.0	23.0	18.3	18.9	15.8	16.1	34.1	26.4	23.4	16.2	14.1	19.8
	19.2	20.8	16.7	18.8	16.9	18.4	14.5	20.7	20.1	20.0	20.6	19.2
	131	119	123	119	108	113	116	108	109	107	104	114
	544	447	470	464	437	413	433	427	421	451	397	420
	9.3	21.2	22.0	33.4	19.0	59.4	48.8	43.2	18.1	−13.3	23.3	25.1
	−9.9	0.4	5.3	14.6	2.1	41.0	34.3	22.6	−2.0	−33.3	2.7	5.9
Profit
	−22.5	1.3	−10.1	0.3	−5.2	34.5	1.5	8.2	−23.5	−43.7	−9.7	−12.1
	−11.1	−7.9	−17.5	0.0	0.0	−5.6	0.0	−151	0.0	−49.8	0.0	0.0
	−33.7	−6.6	−27.6	0.3	−5.2	28.9	1.5	−143	−23.5	−93.5	−9.7	−12.1
	3.9	1.9	4.4	5.6	6.0	14.0	4.3	16.4	7.4	6.5	6.5	7.9
	−4.3	−8.2	−4.4	0.3	−6.0	−6.0	2.8	−42.6	3.8	−18.2	−1.9	0.9
	−0.5	−6.2	0.0	5.9	−0.0	8.0	7.1	−26.2	11.2	−11.7	4.5	8.7
	1.4	1.4	−0.3	−0.4	0.9	1.8	−1.8	0.5	0.0	0.0	0.0	0.0
	−33.6	86.3	−37.1	−15.0	−10.7	0.1	−7.5	−116	−34.7	−81.8	−14.3	−20.8
	−33.2	−0.4	−27.6	−5.6	−5.1	21.0	−5.6	−117	−34.7	−81.8	−14.3	−20.8
	−1.8	85.3	−9.2	−8.9	−6.4	−22.6	0.0	0.0	0.0	0.0	0.0	0.0
	17.3	−11.9	4.4	−1.0	11.9	5.8	−12.1	0.0	−5.9	−0.9	16.4	−2.5
	−16.4	74.4	−32.7	−15.9	1.2	5.9	−19.6	−116	−40.6	−82.7	2.1	−23.3
	−31.7	88.2	−36.2	−14.4	−10.0	−0.7	−4.1	−100	−34.0	−77.1	−11.8	−19.4
	−1.9	−1.9	−0.9	−0.6	−0.7	0.8	−3.3	−15.9	−0.7	−4.6	−2.5	−1.4
Per share
	−₹1.65	₹4.59	−₹1.91	−₹0.76	−₹0.53	−₹0.04	−₹0.24	−₹5.98	−₹2.03	−₹4.64	−₹0.71	−₹1.17
	−₹1.65	₹4.54	−₹1.91	−₹0.76	−₹0.52	−₹0.04	−₹0.24	−₹5.93	−₹2.01	−₹4.58	−₹0.70	−₹1.16
Continuing & discontinued operations
	−1.8	85.5	−9.2	−8.9	−6.4	−22.6	0.0	0.0	0.0	0.0	0.0	0.0
	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other comprehensive income — detail
	17.3	−11.9	4.4	−1.0	11.9	5.8	—	—	—	—	—	—
	−0.1	0.7	0.2	−1.2	0.2	0.2	0.1	−0.2	−0.2	−0.0	0.1	−0.0
	−0.0	0.2	0.1	−0.4	0.1	0.1	—	—	—	—	—	—
	—	—	—	—	—	—	0.0	−0.1	−0.1	−0.0	0.0	−0.0
	19.3	−13.1	4.4	−2.1	11.9	6.6	−13.4	−0.1	−5.5	−1.0	16.3	−3.1
	2.0	−0.8	0.1	−1.9	0.1	1.0	—	—	—	—	—	—
	—	—	—	—	—	—	−1.3	−0.3	0.4	−0.1	−0.0	−0.6
	−14.0	78.6	−31.3	−14.5	1.9	4.4	−15.3	−100.0	−40.4	−78.0	4.4	−21.9
	−2.4	−4.2	−1.4	−1.4	−0.7	1.5	−4.3	−16.1	−0.2	−4.7	−2.3	−1.4
Per share — as-filed variants
	−₹1.60	₹0.35	−₹1.44	−₹0.31	−₹0.22	₹1.17	−₹0.24	−₹5.98	−₹2.03	−₹4.64	−₹0.71	−₹1.17
	−₹1.60	₹0.35	−₹1.44	−₹0.31	−₹0.21	₹1.16	−₹0.24	−₹5.93	−₹2.01	−₹4.58	−₹0.70	−₹1.16
	−₹0.05	₹4.24	−₹0.47	−₹0.45	−₹0.31	−₹1.21	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00
	−₹0.05	₹4.19	−₹0.47	−₹0.45	−₹0.31	−₹1.20	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	214	206	209	213	187	222	217	204	178	140	173	182
	41.2%	48.5%	45.8%	46.3%	44.1%	50.8%	50.1%	48.2%	44.9%	34.9%	44.9%	44.9%
Adjusted (ex-exceptional items) — derived
	−22.5	1.3	−10.1	0.3	−5.2	34.5	1.5	8.2	−23.5	−43.7	−9.7	−12.1
	−11.1	−7.9	−17.5	0.0	0.0	−5.6	0.0	−151	0.0	−49.8	0.0	0.0
	−22.7	89.5	−19.6	−15.0	−10.7	4.2	−7.5	7.2	−34.7	−38.2	−14.3	−20.8
	−₹1.11	₹4.76	−₹1.01	−₹0.76	−₹0.53	−₹1.51	−₹0.24	₹0.37	−₹2.03	−₹2.17	−₹0.71	−₹1.17

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

CAMLINFINE₹82.32

Camlin Fine Sciences Limited

· Chemicals

Annual Quarterly₹ CrorePeersCLEAN DEEPAKNTR BAYERCROP TIRUMALCHM ATUL SHK PAUSHAKLTD ANURASMcap ₹1,581 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	405.9	385.9	401.7	395.9	423.0	433.5	437.5	423.6	459.8	457.2	424.8	519.9
Other Income	1.8	1.7	5.8	1.9	12.1	1.3	9.6	8.6	4.6	2.9	23.9	1.3
Total Income	407.6	387.6	407.5	397.7	435.1	434.8	447.1	432.1	464.4	460.1	448.7	521.2
Expenses
+ Cost of Materials Consumed	206.2	156.2	136.7	214.5	223.1	173.3	194.9	225.9	209.0	267.7	120.7	312.3
+ Purchases of Stock-in-Trade	12.3	39.0	43.3	15.8	53.9	45.4	2.4	17.4	31.9	13.7	18.2	5.8
+ Changes in Inventories	5.2	17.4	81.6	-12.4	-57.9	-2.3	18.1	-6.4	5.8	-33.4	79.9	-12.5
+ Employee Benefit Expense	43.2	45.5	46.2	51.2	52.3	52.0	50.1	59.6	60.3	63.8	65.9	73.4
+ Finance Costs	19.8	14.1	16.2	23.4	26.4	34.1	16.1	15.8	18.9	18.3	23.0	14.0
+ Depreciation & Amortisation	19.2	20.6	20.0	20.1	20.7	14.5	18.4	16.9	18.8	16.7	20.8	19.2
+ Other Expenses	113.9	104.5	107.1	108.5	108.4	116.4	112.6	108.1	119.4	123.4	118.9	131.5
Total Expenses	419.7	397.3	451.2	421.2	426.8	433.3	412.6	437.3	464.1	470.2	447.4	543.8
EBITDA	25.1	23.3	-13.3	18.1	43.2	48.8	59.4	19.0	33.4	22.0	21.2	9.3
EBIT	5.9	2.7	-33.3	-2.0	22.6	34.3	41.0	2.1	14.6	5.3	0.4	-9.9
Profit
PBT before Exceptional Items	-12.1	-9.7	-43.7	-23.5	8.2	1.5	34.5	-5.2	0.3	-10.1	1.3	-22.5
+ Exceptional Items	0.0	0.0	-49.8	0.0	-151.0	0.0	-5.6	0.0	0.0	-17.5	-7.9	-11.1
Pretax Income	-12.1	-9.7	-93.5	-23.5	-142.8	1.5	28.9	-5.2	0.3	-27.6	-6.6	-33.7
+ Current Tax	7.9	6.5	6.5	7.4	16.4	4.3	14.0	6.0	5.6	4.4	1.9	3.9
+ Deferred Tax	0.9	-1.9	-18.2	3.8	-42.6	2.8	-6.0	-6.0	0.3	-4.4	-8.2	-4.3
Tax Expense	8.7	4.5	-11.7	11.2	-26.2	7.1	8.0	-0.0	5.9	0.0	-6.2	-0.5
+ Share of Associates & JVs	0.0	0.0	0.0	0.0	0.5	-1.8	1.8	0.9	-0.4	-0.3	1.4	1.4
Net Income	-20.8	-14.3	-81.8	-34.7	-116.1	-7.5	0.1	-10.7	-15.0	-37.1	86.3	-33.6
+ Net Income — Continuing Ops	-20.8	-14.3	-81.8	-34.7	-116.6	-5.6	21.0	-5.1	-5.6	-27.6	-0.4	-33.2
+ Net Income — Discontinued Ops	0.0	0.0	0.0	0.0	0.0	0.0	-22.6	-6.4	-8.9	-9.2	85.3	-1.8
+ Other Comprehensive Income	-2.5	16.4	-0.9	-5.9	0.0	-12.1	5.8	11.9	-1.0	4.4	-11.9	17.3
Total Comprehensive Income	-23.3	2.1	-82.7	-40.6	-116.1	-19.6	5.9	1.2	-15.9	-32.7	74.4	-16.4
Net Income to Common	-19.4	-11.8	-77.1	-34.0	-100.2	-4.1	-0.7	-10.0	-14.4	-36.2	88.2	-31.7
Minority Interest	-1.4	-2.5	-4.6	-0.7	-15.9	-3.3	0.8	-0.7	-0.6	-0.9	-1.9	-1.9
Per Share
Basic EPS	-1.17	-0.71	-4.64	-2.03	-5.98	-0.24	-0.04	-0.53	-0.76	-1.91	4.59	-1.65
Diluted EPS	-1.16	-0.70	-4.58	-2.01	-5.93	-0.24	-0.04	-0.52	-0.76	-1.91	4.54	-1.65
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax	0.0	0.0	0.0	0.0	0.0	0.0	-22.6	-6.4	-8.9	-9.2	85.5	-1.8
+ Tax — Discontinued Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	5.8	11.9	-1.0	4.4	-11.9	17.3
+ Items NOT to be Reclassified to P&L	-0.0	0.1	-0.0	-0.2	-0.2	0.1	0.2	0.2	-1.2	0.2	0.7	-0.1
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	0.1	0.1	-0.4	0.1	0.2	-0.0
+ Tax on Items NOT to be Reclassified — alt tag	-0.0	0.0	-0.0	-0.1	-0.1	0.0	—	—	—	—	—	—
+ Items to be Reclassified to P&L	-3.1	16.3	-1.0	-5.5	-0.1	-13.4	6.6	11.9	-2.1	4.4	-13.1	19.3
+ Tax on Items to be Reclassified	—	—	—	—	—	—	1.0	0.1	-1.9	0.1	-0.8	2.0
+ Tax on Items to be Reclassified — alt tag	-0.6	-0.0	-0.1	0.4	-0.3	-1.3	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	-21.9	4.4	-78.0	-40.4	-100.0	-15.3	4.4	1.9	-14.5	-31.3	78.6	-14.0
Comprehensive Income — Non-controlling Interests	-1.4	-2.3	-4.7	-0.2	-16.1	-4.3	1.5	-0.7	-1.4	-1.4	-4.2	-2.4
Per Share — as-filed variants
Basic EPS — Continuing Operations	-1.17	-0.71	-4.64	-2.03	-5.98	-0.24	1.17	-0.22	-0.31	-1.44	0.35	-1.60
Diluted EPS — Continuing Operations	-1.16	-0.70	-4.58	-2.01	-5.93	-0.24	1.16	-0.21	-0.31	-1.44	0.35	-1.60
Basic EPS — Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	-1.21	-0.31	-0.45	-0.47	4.24	-0.05
Diluted EPS — Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	-1.20	-0.31	-0.45	-0.47	4.19	-0.05
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	182.3	173.3	140.1	177.8	203.9	217.2	222.2	186.7	213.1	209.2	206.0	214.2
Gross Margin %	44.91	44.91	34.87	44.92	48.21	50.10	50.78	44.07	46.35	45.75	48.50	41.20
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	-12.1	-9.7	-43.7	-23.5	8.2	1.5	34.5	-5.2	0.3	-10.1	1.3	-22.5
− Exceptional Items (reconciliation)	0.0	0.0	-49.8	0.0	-151.0	0.0	-5.6	0.0	0.0	-17.5	-7.9	-11.1
Net Income Adj (tax-effected)	-20.8	-14.3	-38.2	-34.7	7.2	-7.5	4.2	-10.7	-15.0	-19.6	89.5	-22.7
EPS Adj	-1.17	-0.71	-2.17	-2.03	0.37	-0.24	-1.51	-0.53	-0.76	-1.01	4.76	-1.11
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Filed Debt Equity	0.00	0.00	0.00	0.00	—	—	72.00	—	—	—	—	—
Filed Dscr	0.00	0.00	0.00	0.00	—	—	1.00	—	—	—	—	—
Paid Up Equity Capital	16.7	16.7	16.7	16.7	16.7	16.7	18.8	18.8	18.8	19.2	19.2	19.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Camlin Fine Sciences Q2 FY27 results date

Camlin Fine Sciences (NSE: CAMLINFINE) will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, according to the board-meeting notice it filed on 29 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net loss attributable to shareholders was ₹31.7 crore, wider than the loss of ₹10 crore in Q1 FY26 and against a profit of ₹88.2 crore in Q4 FY26. Revenue from operations was ₹520 crore, up 22.7% year on year and up 22.4% from the previous quarter.

Board-meeting notice filed: 29 October 2026
Q2 FY26 results (a year earlier): 10 November 2025
Q1 FY27 results (the latest): 11 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 3 November 2026Tuesday · notice filed 29 Oct
Q1 FY27 net loss: −₹31.7 Crloss ₹10 Cr in Q1 FY26profit ₹88.2 Cr in Q4 FY26
Q1 FY27 revenue: ₹520 Cr+22.7% vs Q1 FY26+22.4% vs Q4 FY26
Q1 FY27 operating margin: −1.9%−2.4 pts vs Q1 FY26−2.0 pts vs Q4 FY26
Q2 FY26 net loss (a year earlier): −₹14.4 CrRevenue ₹460 Cr
Q1 FY27 EPS (basic): −₹1.65

Questions

When will Camlin Fine Sciences announce its Q2 FY27 results?

On 3 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 29 October 2026). Last year it reported Q2 FY26 on 10 November 2025.

What will Camlin Fine Sciences' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net loss attributable to shareholders was ₹14.4 crore and revenue from operations ₹460 crore. The latest quarter, Q1 FY27, had a net loss of ₹31.7 crore and revenue of ₹520 crore.

What was Camlin Fine Sciences' revenue in FY26?

Revenue from operations was ₹1,723 crore in FY26 (April 2025–March 2026), up 3.4% from ₹1,667 crore in FY25. It was ₹1,613 crore in FY24 and ₹1,682 crore in FY23: up 2.5% over three years, 0.8% a year on average.

What were Camlin Fine Sciences' Q1 FY27 results?

Consolidated net loss attributable to shareholders was ₹31.7 crore, wider than the loss of ₹10 crore in Q1 FY26 and against a profit of ₹88.2 crore in Q4 FY26. Revenue from operations was ₹520 crore, up 22.7% year on year and up 22.4% from the previous quarter.

How has Camlin Fine Sciences' profit changed over the last four quarters?

Net profit attributable to shareholders by quarter: a loss of ₹14.4 crore in Q2 FY26, a loss of ₹36.2 crore in Q3 FY26, a profit of ₹88.2 crore in Q4 FY26 and a loss of ₹31.7 crore in Q1 FY27. That is a combined profit of ₹5.9 crore over the four quarters. Revenue from operations: ₹460 crore, ₹457 crore, ₹425 crore and ₹520 crore.

What was Camlin Fine Sciences' net profit in FY26?

Consolidated net profit attributable to shareholders was ₹27.6 crore in FY26 (April 2025–March 2026), against a loss of ₹139 crore in FY25. It was a loss of ₹92.8 crore in FY24 and a profit of ₹52.1 crore in FY23: down 47.0% over three years, an average fall of 19.1% a year.

Where do these Camlin Fine Sciences figures come from?

From Camlin Fine Sciences' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.